Neuren Pharmaceuticals | NEU - Current Assets



Neuren Pharmaceuticals reported AUD399.33M in Current Assets for its fiscal semester ending in December of 2024.


Current Assets Change Date
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Avita Medical AUD 57M 15.96M Dec/2024
Clinuvel Pharmaceuticals AUD 222.06M 20.56M Jun/2024
Dianthus Therapeutics USD 263.6M 17.3M Jun/2025
Genetic Signatures AUD 51.56M 989K Dec/2024
Ionis Pharmaceuticals USD 2.58B 158.22M Jun/2025
Medical Developments International AUD 33.41M 7.26M Dec/2024
Neuren Pharmaceuticals AUD 399.33M 171.29M Dec/2024
Organon & Co USD 4.62B 247M Jun/2025
Paradigm Biopharmaceuticals AUD 32.29M 8.04M Dec/2024
PYC Therapeutics AUD 62.12M 23.49M Dec/2024
Starpharma Holdings AUD 26.25M 6.67M Dec/2024
Tectonic Therapeutic USD 290.85M 143.99M Jun/2025
Telix Pharmaceuticals AUD 918.56M 663.3M Dec/2024
Viatris USD 9.77B 152.2M Jun/2025
Xeris Pharmaceuticals USD 185.58M 17.92M Jun/2025